11q13 allelotype analysis in 27 Northern American MEN1 kindreds identifies two distinct founder chromosomes

Molecular Genetics and Metabolism

Volumn 63, Issue 2, 1998, Pages 151-155

  Emmert Buck, Michael R ^a   Debelenko, Larisa V ^a   Agarwal, Sunita ^b   Kester, Mary Beth ^b   Manickam, Pachiappan ^c   Zhuang, Zhengping ^a   Guru, Siradanahalli C ^c   Olufemi, Shodimu Emmanuel ^c   Burns, A Lee ^b   Chandrasekharappa, Settara C ^c   Lubensky, Irina A ^a   Liotta, Lance A ^a   Skarulis, Monica C ^b   Spiegel, Allen M ^b   Marx, Stephen J ^b   Collins, Francis S ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

Chromosome 11q13; Haplotype; MEN1

Indexed keywords

ALLELE; ARTICLE; CHROMOSOME 11Q; CLINICAL ARTICLE; CLINICAL FEATURE; DNA DETERMINATION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; HAPLOTYPE; HUMAN; MARKER GENE; MULTIPLE ENDOCRINE NEOPLASIA; PEDIGREE ANALYSIS; PRIORITY JOURNAL; PROLACTINOMA;

EID: 0031664490     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.1997.2649     Document Type: Article

References (22)

1. Wermer P. Genetic aspects of adenomatosis of endocrine glands. Am J Med 16:363-371, 1954.
2. Moldawar MP, Nardi GL, Raker GW. Concomittance of multiple adenomas of the parathyroids and pancreatic islet cells with tumor of the pituitary; a syndrome with familial incidence. Am J Med Sci 228:190, 1954.
3. Metz DC, Jensen RT, Bale AE, Skarulis MC, Eastman RC, Nieman L, Norton JA, Friedman E, Larsson C, Amorossi A, Brandi M-L, Marx SJ. Multiple endocrine neoplasia type I. Clinical features and management. In The Parathyroids (Bilezekian JP, Levine MA, Marcus R, Eds.). New York: Raven, 1994, pp. 591-646.
4. Larsson C, Skogseid B, Oberg K, Nakamura Y, Nordenskjold M. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332:85-87, 1988.
5. Bale SJ, Bale AE, Stewart K, Dachowski L, McBride OW, Glaser T, Green JEIII, Mulvihill JJ, Brandi ML, Sakaguchi K, Aurbach GD, Marx SJ. Linkage analysis of multiple endocrine neoplasia type 1 with INT 2 and other markers on chromosome 11. Genomics 4:320-322, 1989.
6. Nakamura Y, Larsson C, Jilier C, Byström C, Skogseid B, Wells S, Öberg K, Carlson M, Taggart T, O'Conell P, Leppert M, Lalouel J-M, Nordenskjöld M. Localization of the genetic defect in multiple endocrine neoplasia type 1 within a small region of chromosome 11. Am J Hum Genet 44:751-755, 1989.
7. Thakker RV, Wooding C, Pang JT, Farren B, Harding B, Andersen DC, Besser GM, Bouloux P, Brenton DP, Buchanan KD, Edwards CR, Heath DA, Jackson CE, Jansen S, Lips K, Norum RA, Sampson J, Shalet SM, Taggart RT, Tailor D, Wheeler MH, Woollard PM, Yates J. Linkage analysis of 7 polymorphic markers at chromosome 11p11.2-11q13 in 27 multiple endocrine neoplasia type 1 families. Ann Hum Genet 57:17-25, 1993.
8. Teh BT, Hii SI, David R, Parameswaran V, Grimmond S, Walters MK, Tan TT, Nancarrow DJ, Chan SP, Mennon J, Larsson C, Zaini A, Khalid BAK, Shepherd JJ, Cameron DP, Hayward NK. Multiple endocrine neoplasia type 1 (MEN1) in two Asian families. Hum Genet 94:468-472, 1994.
9. Petty EM, Green JS, Marx SJ, Taggart RT, Farid N, Bale AE. Mapping of the gene for hereditary hyperparathyroidism and prolactinoma to chromosome 11q: Evidence for a founder effect in the patients from Newfoundland. Am J Hum Genet 54:1060-1066, 1994.
10. Smith CM, Wells SA, Gerhard DS. Mapping eight new polymorphisms in 11q13 in the vicinity of multiple endocrine neoplasia type 1. Identification of a new distal recombinant. Hum Genet 96:377-387, 1995.
11. Kytölä S, Leisti J, Winqvist R, Salmela P. Improved carrier testing for multiple endocrine neoplasia, type 1, using new microsatellite-type DNA markers. Hum Genet 96:449-453, 1995.
12. Courseaux A, Grosgeorge J, Gaudray P, Pannett AAJ, Forbes SA, Williamson C, Bassett D, Thakker RV, The BT, Farnebo F, Shepherd J, Skogseid B, Larsson C, Giraud S, Zhang CX, Salandre J, Calander A. Definition of the minimal MEN1 candidate area based on a 5-Mb integrated map of proximal 11q13. Genomics 37:354-365, 1996.
13. Debelenko LV, Emmert-Buck MR, Manickam P, Kester M-B, Guru SC, DiFranco EM, Olufemi S-E, Agarwal S, Lubensky IA, Zhuang Z, Burns AL, Spiegel AM, Liotta LA, Collins FS, Marx SJ, Chandrasekharappa SC. Haplotype analysis defines a minimal interval for multiple endocrine neoplasia type 1 (MEN1) gene. Cancer Res 57:1039-1042, 1997.
14. Emmert-Buck MR, Lubensky IA, Dong Q, Chandrasekharappa C, Guru SC, Manickam P, Keseter M, Olufemi S-E, Agarwal S, Burns AL, Spiegel AM, Collins FS, Marx SJ, Zhuang Z, Liotta LA, Debelenko LV. Localization of the multiple endocrine neoplasia type I (MEN1) gene based on tumor deletion mapping. Cancer Res 57:1855-1858, 1997.
15. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi S-E, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Crabtree JS, Wang Y, Roe BA, Weisemann J, Boguski MS, Agarwal SK, Kester MB, Kim YS, Heppner C, Dong Q, Spiegel AM, Burns AL, Marx SJ. Positional cloning of the gene for multiple endocrine neoplasia type 1. Science 276:404-407, 1997.
16. James MR, Richard CW, Schott JJ, Yousry C, Clark K, Bell JD, Terwilliger JD, Hazan J, Dubay C, Vignal A, Agrapart M, Imai T, Nakamura Y, Polymeropoulos M, Weissenbach J, Cox DR, Lathrop GM. A radiation hybrid map of 506 STS markers spanning human chromosome 11. Nature Genet 8:70-76, 1994.
17. Fain PR, Kort EN, Yousry C, James MR, Litt M. A high resolution CEPH crossover mapping panel and integrated map of chromosome 11. Hum Mol Genet 5:1631-1636, 1996.
18. Manickam P, Guru SC, Debelenko LV, Agarwal SK, Olufemi S-E, Weissman J, Boguski M, Crabtree J, Wang Y, Roe B, Lubensky IA, Zhuang Z, Kester MB, Burns AL, Spiegel AM, Marx SJ, Liotta LA, Emmert-Buck MR, Collins FS, Chandrasekharappa SC. Eighteen new polymorphic markers in the multiple endocrine neoplasia type I (MEN1) region. Hum Genet 101:102-108, 1997.
19. Emmert-Buck MR, Roth MJ, Zhuang Z, Campo E, Rozhin J, Sloane BF, Liotta LA, Stetler-Stevenson WG. Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. Am J Pathol 145:1285-1290, 1994.
20. Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z, Goldstein SR, Weiss RA, Liotta LA Laser capture microdissection. Science 274:998-1001, 1996.
21. Lubensky IA, Debelenko LV, Zhuang Z, Emmert-Buck MR, Dong Q, Chandrasekharrappa S, Guru SC, Manickam P, Olufemi S-E, Marx SJ, Spiegel AM, Collins FS, Liotta LA. Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN1 patients. Cancer Res 56:5272-5278, 1996.
22. Agarwal SK, Kester MB, Debelenko LV, Heppner C, Emmert-Buck MR, Skarulis MC, Doppman JL, Kim YS, Lubensky IA, Zhuang Z, Boguski MS, Weisemann J, Green JS, Guru SC, Manickam P, Olufemi S-E, Liotta LA, Chandrasekharappa SC, Collins FS, Spiegel AM, Burns AL, Marx SJ. Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type I and related states. Hum Mol Genet 6:1169-1175, 1997.